Searched for
DRUG INDUSTRY
Biocon founder Kiran Mazumdar Shaw says India must shift pharma industry from generics to innovation-led growthKiran Mazumdar-Shaw emphasized the importance of building an innovation-driven pharmaceutical industry in India. She highlighted the need f...- School Assembly News Headlines, October 14, 2026: Check national, international, business, sports updates and thought of the daySchool assemblies are essential in keeping students updated on crucial happenings both nationally and globally. Recently, the Supreme Court...
- Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-ShawBiocon chairperson Kiran Mazumdar-Shaw calls for greater use of digital technology to speed up drug development, as industry leaders push f...
- Canadians could claim up to $10,000 under Carney’s heat pump rebate: Check date, who qualifies and when applications openCanadian Prime Minister Mark Carney has announced a $2 billion national heat pump rebate program aimed at helping Canadians lower home ener...
- Our central mission must be patient-centric innovation: JP NaddaJ P Nadda urges industry to take discoveries ‘from bench to bedside’ as the FICCI–Lilly Bharat Life Sciences Award backs its inaugural coho...
- Ashish Kacholia sells over 2 lakh Carysil shares in Q2. How has the stock fared?Ace investor Ashish Kacholia trimmed his stake in Carysil by over 2 lakh shares during the July-September quarter of FY27, reducing his hol...
- Apollo, Max Health, other hospital stocks rally up to 5% despite cancer drug price caps. Why Jefferies stays bullishHospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing med...
- Form panel to curb pharma freebies: SCThe Supreme Court has ordered the government to establish a committee to investigate unethical pharmaceutical marketing. The committee is t...
- Experiments on animals set to become easierThe Centre plans to significantly change the regulations governing animal experimentation. The proposed rules aim to allow institutional et...
- Govt set to cap trade margins on more cancer drugs before SC hearingThe Indian government plans to announce a new list of cancer drugs for trade margin rationalisation today. Union Health Minister JP Nadda w...
- HCLTech bets on industry AI to turn pilots into business gainsThe technology services company on October 8 announced a portfolio of 20 Industry AI Solutions ranging banking, healthcare and life science...
- Supreme Court seeks committee to curb pharma firms’ unethical marketing practicesThe Supreme Court has directed the government to form a committee regarding pharmaceutical marketing regulations. This follows concerns ove...
- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
- Aragen Life Sciences begins operations at high-potency platform in HyderabadAragen Life Sciences has initiated operations at its new high-potency manufacturing platform in Hyderabad. The facility, measuring 15,000 s...
- Indian SME pharma firms see shift of orders from China; cost, quality concerns remainSmall and mid-sized Indian pharmaceutical firms are witnessing a shift in orders away from China. As Western buyers diversify their supply ...
- Centre may seek legal view on licensing of sterile drugsThe government is actively exploring a proposal to expand central licensing authority over all sterile drug products following a recent Sup...
- Indian companies must invest in R&D, move from generics to innovation-led industry: Pharma leadersIndian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...
- ‘India’s biotech ecosystem holds tremendous promise’: Eli Lilly CEOEli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...
- From Jab to Pills: Novo Nordisk, Eli Lilly set to take obesity drug battle to IndiaIndia’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...
- Amit Shah pledges to end drug menace in Punjab by 2029Amit Shah addressed a rally in Jalandhar as part of the BJP's 'Nasha Mukt Punjab Yatra'. He highlighted drugs as a primary issue for the 20...
Load More
